One additional COVID-19 death reported in London-Middlesex

Cornelia Mascio
Gennaio 25, 2021

A person infected with a highly-contagious coronavirus variant from the United Kingdom has been linked to a second long-term care home outbreak in the Simcoe-Muskoka public health region, officials said Sunday.

The U.K. variant of COVID-19 behind a devastating outbreak at a long-term care home in Barrie, Ont., is also being investigated as the possible source of infections at a second facility in the region.

No new COVID-19 facility outbreaks were declared in the area, but outbreaks were declared over at a manufacturing workplace (14 cases connected), a vehicle dealership and service shop (three cases), an industrial workplace (two cases), and a congregate setting (19 cases total, two cases in staff).

The health unit said it is investigating "all other connections" to the person who tested positive.

There are now 37 active COVID-19 outbreaks in Waterloo Region. Genome sequencing on six COVID-19 samples from the home have been identified as the highly contagious variant.

"The percent positivity was relatively lower among persons living in long-term care homes (4.5%), compared to those not living in long-term care (5.5%)", ICES said.

On Sunday, Medical Officer of Health Dr. Charles Gardner, revealed seven more residents and one essential care giveer have died, bringing Roberta Place's death toll 41.

ICES provided an overview of the sociodemographic and clinical characteristics of individuals in Ontario who tested and confirmed positive for COVID-19 during the week of January 10 to 16. However, it wasn't until January 20 that the health unit believed the U.K variant was present.

Extending the length of isolation for cases and close contacts.

According to the statement, the new variant is concerning as it is apparently known to transmit easily, further resulting "in much larger numbers of cases in a very rapid fashion".

"We appreciate all the efforts from our partners in the community with the rollout of the vaccine and will continue working closely with them as additional doses are available for deployment", she said.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE